The U.S. Food and Drug Administration (FDA) has cleared Agfa HealthCare's DR 800 multipurpose digital radiography (DR) system with tomosynthesis capability.
The system supports radiography, fluoroscopy, multislice, and advanced clinical applications, and its tomosynthesis function synthesizes slices from a single sweep, the company said. DR 800 features Agfa's Dynamic Musica image processing software, which includes tomosynthesis tools, according to the firm.
DR 800 is not yet available in Canada, Agfa said.
